跳至主要内容
临床试验/ISRCTN98070045
ISRCTN98070045已完成不适用

Study on the use of carbetocin (Pabal®) in comparison with oxytocin (Syntocinon®) for the prevention of postpartum haemorrhage (the need for additional uterotonic medication) after elective caesarean section

Ferring B.V. (Netherlands)0 个研究点目标入组 1,500 人开始时间: 2012年3月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
Female

入选标准

  • Charts of women who have undergone elective CS under epidural and/or spinal anaesthesia and treated with carbetocin or oxytocin.

排除标准

  • Contraindications, warnings, precautions and interactions with other drugs mentioned in the summary of product characteristics of carbetocin and oxytocin.

研究者

发起方
Ferring B.V. (Netherlands)

相似试验